Oppenheimer Inc. (OPY)
NYSE: OPY
· Real-Time Price · USD
69.76
-0.80 (-1.13%)
At close: Aug 19, 2025, 3:59 PM
69.25
-0.73%
After-hours: Aug 19, 2025, 06:15 PM EDT
-1.13% (1D)
| Bid | 67.32 |
| Market Cap | 726.96M |
| Revenue (ttm) | 1.49B |
| Net Income (ttm) | 87.57M |
| EPS (ttm) | 7.71 |
| PE Ratio (ttm) | 9.05 |
| Forward PE | 86.69 |
| Analyst | n/a |
| Ask | 75 |
| Volume | 30,003 |
| Avg. Volume (20D) | 61,080 |
| Open | 70.55 |
| Previous Close | 70.56 |
| Day's Range | 69.42 - 71.38 |
| 52-Week Range | 47.39 - 77.83 |
| Beta | 1.22 |
3 months ago
+0.9%
Shares of financial companies are trading higher a...
Unlock content with
Pro Subscription
3 months ago
+1.78%
Shares of financial companies are trading higher amid Treasury Secretary Scott Bessent's remarks about trade de-escalation with China, which may help restore investor confidence towards the sector.
2 weeks ago · https://thefly.com
Y-mAbs Therapeutics downgraded to Perform from Outperform at OppenheimerOppenheimer analyst Jeff Jones downgraded Y-mAbs Therapeutics without a price target to Perform from Outperform after the company agreed to be acquired by SERB Pharmaceuticals for $8.60 per share in c...
